ArticleRenal failure2026

A tri-scale in silico framework integrating pharmacovigilance and mechanistic modeling suggests tepotinib-associated acute kidney injury risk.

Rubin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.